Abstract
Background: A lot of clinicians use heparin in patients with posterior circulation stroke. Frequency and risk factors of symptomatic intracerebral hematoma (ICH) in posterior circulation infarct patients anticoagulated with unfractionated heparin are not known.
Methods: To determine the incidence and the risk factors of the heparin-related ICH in posterior circulation infarct patients, we retrospectively reviewed the clinical features of 37 patients who had acute posterior circulation infarct and received intravenous heparin after they underwent brain computed tomographic scans and diffusion-weighted imaging (DWI). Follow-up brain scans were obtained at any time if clinical symptoms worsened. Volumes of acute posterior circulation infarction were calculated on DWI.
Results: Of 37 patients, four (10.8%) developed symptomatic ICH during heparin infusion. The location of ICH was cerebellum in all the hemorrhagic worsening patients. We found that the size of an acute infarction calculated on DWI is the risk factor of symptomatic ICH during intravenous heparin therapy in patients with posterior circulation infarct.
Conclusions: Until a large prospective study is performed, it may be prudent to avoid heparin infusion in patients with large posterior circulation infarct documented on DWI.
Similar content being viewed by others
References
Millikan CH (1971) Reassessment of anticoagulation therapy in various type of occlusive cerebrovascular disease. Stroke 2:201–208
Millikan CH, Siekert RG, Shick RM (1955) Studies in cerebrovascular disease. III. The use of anticoagulant drugs in the treatment of insufficiency or thrombosis within the basilar arterial system. Mayo Clin Proc 30:116–126
Millikan CG, Siekert RG, Whisnant JP (1958) Anticoagulant therapy in cerebrovascular disease: Current status. JAMA 166:587–592
Siekert RG, Whisnant JP, Millikan CH (1963) Surgical and anticoagulant therapy of occlusive cerebrovascular disease. Ann Intern Med 58:637–641
Whisnant JP (1961) Discussion. In: Millikan C, Siekert R, Whisnant JP (eds.) Cerebral vascular diseases: Third princeton conference on cerebrovascular diseases. Orlando, Fla, Grune & Stratton, pp. 156–157
Al-Sadat A, Sunbulli M, Chaturvedi S (2002) Use of intravenous heparin by North American neurologists: do the data matter? Stroke 33:1574–1577
Tettenborn B (2001) Extended infarcts in the posterior circulation (brainstem/cerebellum). In: Bogousslavsky J, Caplan LR (eds.) Stroke Syndromes, 2nd edition Cambridge, Cambridge University Press, pp. 557–563
Caplan L (2000) Posterior circulation ischemia: then, now, and tomorrow. The Thomas Willis Lecture-2000. Stroke 31:2011–2023
Victor M, Ropper AH (2001) Cerebrovascular diseases. In: Adams and Victor’s principles of neurology, 7th edn. McGraw-Hill, New York, 821–924
Misra M, Alp MS, Hier D, Ausman JI (2004) Multidisciplinary treatment of posterior circulation ischemia. Neurol Res 26:67–73
Al-Sadat A, Sunbulli M, Chaturvedi S (2002) Use of intravenous heparin by North American neurologists: do the data matter? Stroke 33:1574–1577
Yoon SS, Heo SH, Park KC, et al. (2005) The Usage of Intravenous Heparin in Acute Ischemic Stroke in 10 Teaching Hospitals. Journal of the Korean Neurological Association 23:446–450
Adams H, Adams R, Del Zoppo G, Goldstein LB (2005) Stroke Council of the American Heart Association; American Stroke Association. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 36:916–923
International Stroke Trial Collaboration Group (1997). The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute stroke. Lancet 349:1569–1581
Hacke W, Zeumer H, Ferbert A, Bruckmann H, del Zoppo GJ (1988) Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 19:1216–1222
Cerebral embolism study group (1983). Immediate anticoagulation of embolic stroke: a randomized trial. Stroke 14:668–676
Calander L, Ortega JF, Berbejo F, Portera A (1983) Cerebral embolism and anticoagulation. (Letter to the editor) Neurology 33:1103–1106
Chamorro A, Vila N, Saiz A, Alday M, Tolosa E (1995) Early anticoagulation after large cerebral embolic infarction: A safety study. Neurology 45:861–865
Chamorro A, Vila N, Ascaso C, Blanc R (1999) Heparin in acute stroke with atrial fibrillation. Clinical relevance of very early treatment. Arch Neurol 56:1098–1102
Camerlingo M, Casto L, Censori B, et al. (1994) Immediate anticoagulation with heparin for first-ever ischemic stroke in the carotid artery territories observed within 5 hours of onset. Arch Neurol 51:462–467
Cerebral embolism study group (1987). Cardioembolic stroke, early anticoagulation, and brain hemorrhage. Arch Intern Med 147:636–640
Cerebral embolism study group (1984). Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Stroke 15:779–789
Glass TA, Hennessey PM, Pazdera L, et al. (2002) Outcome at 30 days in the New England Medical Center Posterior Circulation Registry. Arch Neurol 59:369–376
Kim HJ, Cho HI, Lee DS (2000) Should therapeutic range in heparin therapy be changed with new reagent for activated partial thromboplastin time? Korean J. Med. 59:505–510
Hornig CR, Bauer T, Simon C, Trittmacher S, Dorndorf W (1993) Hemorrhagic transformation in cardioembolic cerebral infarction. Stroke 24:465–468
Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR 149:351–356
Kase CS, Robinson RK, Stein RW, et al. (1985) Anticoagulant-related intracerebral hemorrhage. Neurology 35:943–948
Radberg JA, Olsson JE, Radberg CT (1991) Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment. Stroke 22:571–576
Brandt T, von Kummer R, Muller-Kuppers M, Hacke W (1996) Thrombolytic therapy of acute basilar artery occlusion variables affecting recanalization and outcome. Stroke 27:875–881
Hornig CR, Buttner T, Hoffmann O, Dorndorf W (1992) Short-term prognosis of vertebrobasilar ischemic stroke. Cerebrovasc Dis 2:273–281
Lutsep HL, Albers GW, DeCrespigny A, Kamat GN, Marks MP, Moseley ME (1997) Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol 41:574–580
Fennerty AG, Renowden S, Scolding N, Bentley DP, Campbell IA, Routledge PA (1986) Guidelines to control heparin treatment. Brit Med J 292:579–580
Elliott GC, Hiltunen SJ, Suchyta M, et al. (1994) Physician-guided treatment compared with a heparin protocol for deep vein thrombosis. Arch Intern Med 154:999–1004
Cory Toth, Chris Voll (2002) Validation of a weight-based nomogram for the use of intravenous heparin in transient ischemic attack or stroke. Stroke 33:670–674
Barnes C, Blanchette V, Canning P, Carcao M (2005) Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatment. Transfus Med 15:145–150
Nilsson OG, Lindgren A, Stahl N, Brandt L, Saveland H (2000) Incidence of intracerebral and subarachoid hemorrhage in southern Sweden. J Neurol Neurosurg Psych 69:601–607
Tanaka H, Ueda Y, Date C, et al. (1981) Incidence of stroke in Shibata, Japan, 1976–1978, Stroke 12:460–466
Tanaka A, Ueno Y, Nakayama Y, Takano K, Takebayashi S. (1999) Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas. Stroke 30:1637–1642
Kang K, Lee YS, Kim NH, Kim DE, Park SH (2003) Associated ischemic lesions in intracranial hemorrhage: MRI study. Eur Neurol 49:94–97
Smith EE, Rosand J, Knudsen KA, Hylek EM, Greenberg SM (2002) Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology 59:193–197
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kang, K., Yoon, BW. & Kang, K. Symptomatic intracerebral hematomas in posterior circulation stroke patients anticoagulated with heparin. J Thromb Thrombolysis 21, 249–255 (2006). https://doi.org/10.1007/s11239-006-6967-5
Issue Date:
DOI: https://doi.org/10.1007/s11239-006-6967-5